Antibody veteran David Chiswell, Interim CEO and Chair of Cambridge-based antibody developer Kymab, is taking...
Up to date
Appointments
The EMA’s Committee for Medicinal Products for Veterinary Use (CVMP) has unanimously appointed David Murphy...
Torsten Hombeck will take charge of the commercial activities and the general strategy of Promethera...
Harriet Fear, CEO of not-for-profit One Nucleus, has been appointed a Member of the Order of the British...
UK biotech Bicycle Therapeutics has established US operations in Cambridge (MA). Rosamund Deegan, appointed...
Share
